2-Substitution of Adenine Nucleotide Analogues Containing a Bicyclo[3.1.0]hexane Ring System Locked in a Northern Conformation: Enhanced Potency as P2Y1Receptor Antagonists
- 14 October 2003
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 46 (23) , 4974-4987
- https://doi.org/10.1021/jm030127+
Abstract
Preference for the northern (N) ring conformation of the ribose moiety of adenine nucleotide 3‘,5‘-bisphosphate antagonists of P2Y1 receptors was established by using a ring-constrained methanocarba (a bicyclo[3.1.0]hexane) ring as a ribose substitute (Nandanan et al. J. Med. Chem. 2000, 43, 829−842). We have now combined the ring-constrained (N)-methanocarba modification with other functionalities at the 2-position of the adenine moiety. A new synthetic route to this series of bisphosphate derivatives was introduced, consisting of phosphorylation of the pseudoribose moiety prior to coupling with the adenine base. The activity of the newly synthesized analogues was determined by measuring antagonism of 2-methylthio-ADP-stimulated phospholipase C (PLC) activity in 1321N1 human astrocytoma cells expressing the recombinant human P2Y1 receptor and by using the radiolabeled antagonist [3H]2-chloro-N6-methyl-(N)-methanocarba-2‘-deoxyadenosine 3‘,5‘-bisphosphate 5 in a newly developed binding assay in Sf9 cell membranes. Within the series of 2-halo analogues, the most potent molecule at the hP2Y1 receptor was an (N)-methanocarba N6-methyl-2-iodo analogue 12, which displayed a Ki value in competition for binding of [3H]5 of 0.79 nM and a KB value of 1.74 nM for inhibition of PLC. Thus, 12 is the most potent antagonist selective for the P2Y1 receptor yet reported. The 2-iodo group was substituted with trimethyltin, thus providing a parallel synthetic route for the introduction of an iodo group in this high-affinity antagonist. The (N)-methanocarba-2-methylthio, 2-methylseleno, 2-hexyl, 2-(1-hexenyl), and 2-(1-hexynyl) analogues bound less well, exhibiting micromolar affinity at P2Y1 receptors. An enzymatic method of synthesis of the 3‘,5‘-bisphosphate from the corresponding 3‘-monophosphate, suitable for the preparation of a radiophosphorylated analogue, was explored.Keywords
This publication has 45 references indexed in Scilit:
- Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor familyTrends in Pharmacological Sciences, 2003
- P2 receptor‐types involved in astrogliosis in vivoBritish Journal of Pharmacology, 2001
- Effects of purine and pyrimidine nucleotides on intracellular Ca2+ in human eosinophils: Activation of purinergic P2Y receptorsJournal of Allergy and Clinical Immunology, 2001
- Immunohistochemical localization of the P2Y1 purinergic receptor in Alzheimerʼs diseaseNeuroReport, 2000
- Activity of novel adenine nucleotide derivatives as agonists and antagonists at recombinant rat P2X receptorsDrug Development Research, 2000
- (1S,2R)-[(Benzyloxy)methyl]cyclopent-3-enol. A Versatile Synthon for the Preparation of 4‘,1‘a-Methano- and 1‘,1‘a-Methanocarbocyclic NucleosidesThe Journal of Organic Chemistry, 1997
- Cloning and Tissue Distribution of the Human P2Y1ReceptorBiochemical and Biophysical Research Communications, 1996
- Development of 123I-labelled NNC 13-8241 as a radioligand for SPECT visualization of benzodiazepine receptor bindingNuclear Medicine and Biology, 1996
- Synthesis and radioiodination of N-Boc-p-(tri-n-butylstannyl)-L-phenylalanine tetrafluorophenyl ester: Preparation of a radiolabeled phenylalanine derivative for peptide synthesisBioconjugate Chemistry, 1993
- Cloning and functional expression of a brain G‐protein‐coupled ATP receptorFEBS Letters, 1993